VHIR inaugurates the Master's Degree in Translational Biomedical Research

Barcelona, October 13, 2014

This Friday, October 10, the Vall d’Hebron Institute of Research (VHIR) has celebrated the opening day of the first edition of the Official Master’s Degree in Translational Biomedical Research. In the ceremony, a representative of Banco Santander, Pfizer, Promax, Fenin and the VHIR have given the 6 sponsored grants that will cover the full cost of registration to the students with the best qualifications.

VHIR’s Director, Dr. Joan Comella, has transmitted to the 37 students enrolled in the master the passion, enthusiasm and illusion put by the researchers in the program; researchers that will train them in their specialties, as teachers of the master.

Teachers, sponsors and scholarship students in the master
Teachers, sponsors and scholarship students in the master

The co-coordinator of the master, Dr. Anna Meseguer, has explained the details of the program that she has designed together with Dr. Francina Munell, with the aim of training researchers of excellence that will be able to contribute to the success of translational biomedical research in the future. The master is directed to a scientific career, gives access to the doctorate program, and offers the students the possibility of choosing an area in the biomedicine field in which to study and do their internships.

At the ceremony were also present the Vice-Rector of Strategic Projects and Planification at UAB, Dr. Lluís Tort; the Assistencial Director at the Vall d’Hebron University Hospital, Dr. Jaume Roigé, and the Teaching Director at the Hospital, Dr. M. Josep Cerqueira .

PROMAX Health is a division of PROMAX ELECTRONICA SL that takes care of the design, manufacture and marketing of all kinds of electronic-based products for aesthetic applications. PROMAX was founded in Barcelona in 1963 and today is a company with great international experience and investment in R + D + i that exceeds 15% of its sales volume.